Abstract
Arginine methylation is a prevalent post-translational modification in eukaryotic cells. Two significant debates exist within the field: do these enzymes dimethylate their substrates in a processive or distributive manner, and do these enzymes operate using a random or sequential method of bisubstrate binding? We revealed that human protein arginine N-methyltransferase 1 (PRMT1) enzyme kinetics are dependent on substrate sequence. Further, peptides containing an Nη-hydroxyarginine generally demonstrated substrate inhibition and had improved KM values, which evoked a possible role in inhibitor design. We also revealed that the perceived degree of enzyme processivity is a function of both cofactor and enzyme concentration, suggesting that previous conclusions about PRMT sequential methyl transfer mechanisms require reassessment. Finally, we demonstrated a sequential ordered Bi-Bi kinetic mechanism for PRMT1, based on steady-state kinetic analysis. Together, our data indicate a PRMT1 mechanism of action and processivity that might also extend to other functionally and structurally conserved PRMTs.
Original language | English |
---|---|
Pages (from-to) | 85-99 |
Number of pages | 15 |
Journal | ChemBioChem |
Volume | 19 |
Issue number | 1 |
DOIs | |
Publication status | Published - 4 Jan 2018 |
Keywords
- Amino Acid Sequence
- Arginine/metabolism
- Biocatalysis
- Humans
- Kinetics
- Mass Spectrometry
- Methylation
- Peptides/analysis
- Protein-Arginine N-Methyltransferases/genetics
- Recombinant Proteins/biosynthesis
- Repressor Proteins/genetics
- Substrate Specificity